with signs of active bleeding (figure 1). There was no evidence of esophageal or gastric varices.
The proximal portion of the stomach revealed changes consistent with portal hypertensive gastropathy, characterized by the so-called "mosaic" pattern of the gastric wall along with mucosal red spots, without active bleeding. The bleeding sites were successfully treated with argon plasma coagulation (APC). He was monitored closely and had no further episodes of bleeding. His hemoglobin remained stable before discharge. The patient was lost to follow-up at our facility.
Case Presentation 2
A Caucasian female, aged 68 years, was admitted with complaints of exertional dyspnea and orthopnea of 2 weeks duration. She denied any chest pain or palpitations. Past medical history was significant for coronary artery disease, morbid obesity, hypertension, and poorly controlled type 2 diabetes mellitus.
Her vital signs showed a temperature of 97. g/dL) with a total iron binding capacity of 570 g/dL (reference range 260-420 g/dL).
The patient received four units of packed red cell transfusion, and her hematocrit was closely monitored. She underwent an EGD, which showed areas of hyperemic streaks alternating with normal-appearing mucosa in the antrum, consistent with "watermelon stomach" (figure 2A). A biopsy was obtained. The bleeding sites responded well to APC (figure 2B). The hemoglobin remained stable post-procedure. The gastric antral biopsy showed patchy fibromuscular proliferation of the lamina propria, accompanied by dilated/congested capillaries and fibrin thrombi; the histologic features were characteristic of GAVE (figure 3).
Over an 18-month follow-up period, the patient was treated with four sessions of APC. She required a blood transfusion for severe anemia on two occasions. After being placed on iron supplementation, her hemoglobin level increased from 8.6 gm/dL to 10.5 gm/dL, and there has been a significant reduction in transfusion dependence.
Discussion
The first report of GAVE in the literature in 1953 was by Rider et al 2 Generally, GAVE is associated with underlying chronic illness. Cirrhosis of the liver has been found in 30% of cases. 4 Among patients without cirrhosis, GAVE is usually associated with underlying autoimmune conditions. 5 Gostout et al 5 reported that 62% of patients had coexistent autoimmune connective tissue disorder, particularly Raynaud's phenomenon, which is noted in 31% of patients with GAVE. Other underlying conditions include systemic sclerosis and CREST syndrome (calcinosis, Raynaud's syndrome, esophageal dysmotility, sclerodactyly, and telangiectasia). [4] [5] [6] [7] There have been published case reports of GAVE in patients with essential hypertension, 8 chronic renal failure, 8 acute myeloid leukemia, 9 and bone marrow transplant.
10
In a single-center study of 45 patients with GAVE, 71% were female, with an average age of 73 years. 5 In that study, approximately 89% of patients presented with transfusion-dependent anemia. 5 More recently, two papers have reported two characteristic endoscopic appearances of GAVE with different epidemiological aspects. Cirrhosis is commonly associated with a diffuse appearance of GAVE, involving the whole antrum without interruption; whereas non-cirrhotic patients are more likely to have a typical striped "watermelon" appearance. 11, 12 Our two patients fit these respective endoscopic patterns. Epidemiological differences have been noted in these two groups, and characteristics of the two patterns are listed in table 1.
5,11
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The pathophysiology of GAVE remains unclear. Several theories have been proposed, including achlorhydria, hypergastrinemia, and low pepsinogen levels. The pathogenesis of the histologic changes, most notably the lamina propria fibromuscular proliferation and vascular dilatation with thrombosis, is unclear. Increased levels of hormones with vasodilating properties, such as gastrin and prostaglandin E 2 , have been observed in patients with GAVE, and it has been suggested that failure of liver processing functions may lead to a build-up of these hormones, contributing to the pathogenesis of GAVE. 13 Several studies have suggested the mechanical stress theory in the pathogenesis of GAVE.
Charneua et al 14 found that antral motility time was significantly increased in patients with GAVE when compared to healthy controls. Quintero et al 15 postulated that peristaltic waves of loosely attached antral mucosa draw the mucosa in longitudinal folds and induce fibromuscular proliferation and secondary formation of ectatic vessels. Fibromuscular proliferation and capillary ectasia with microvascular thrombosis of the lamina propria form the histological hallmark of GAVE; the theory of mechanical stress is therefore strengthened by the histological findings in GAVE. 10, [16] [17] [18] Due to the increasing use of endoscopy and increased awareness of the condition, GAVE is now more frequently diagnosed. 18 It is important that GAVE be distinguished from portal hypertensive gastropathy (PHG) and antral gastritis, especially in patients with portal hypertension. Patients with GAVE have more advanced cirrhosis (by Child-Pugh scoring), lower serum gastrin, and greater blood loss than patients with PHG. 19, 20 While PHG can be controlled
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Endoscopically, PHG is typically more predominant in the fundus and the body of the stomach, whereas GAVE mainly involves the antrum. 9, 19 However, severe PHG can occur in the antrum and resemble GAVE. 21 It is unclear as to whether GAVE may involve the proximal stomach. In two separate published case series, the patient numbers were small, and neither documented the presence of thrombi at the proximal stomach; therefore, it is possible that some patients had coexistent GAVE and PHG. 22, 23 The role of biopsies becomes important, since microscopically, GAVE demonstrates more prominent vascular ectasia, fibrin thrombosis (P = 0.006), and fibromuscular proliferation/fibrohyalinosis than PHG. 19 Treatment of GAVE includes initial resuscitation and symptomatic therapy with intravenous fluids and blood products. 17 Medical therapy aimed at reducing portal pressures has had limited success in the treatment of GAVE. 16 Corticosteroids have been used in patients to treat GAVE; in a case series of eleven patients treated with oral steroids, six had complete resolution of bleeding over a mean follow-up period of three years. 24, 25 There have been a few reports where control of bleeding was achieved with estrogen and progesterone. 26, 27 The rationale for hormonal therapy was the observation that epistaxis due to
Osler-Weber-Rendu syndrome decreased during pregnancy. In a study involving six patients with GAVE, Tran et al 26 documented cessation of bleeding and reduction in transfusion requirements in patients treated with ethinyl estradiol with no change in endoscopic appearance.
Gastric antral vascular ectasia Page 9 Copyright ©2012 Marshfield Clinic There have also been reports of using tranexamic acid in the treatment of GAVE, with reduction in bleeding and transfusion requirements. 28 The mainstay of therapy remains endoscopic. 13, 17, 18, 29, 30 Neodymium: yttrium-aluminum-garnet (Nd:YAG) laser has been widely used in the treatment of GAVE. 17, 29 In one study, 13
transfusion-dependent patients were treated with Nd:YAG laser, of whom 12 had remarkable response with elimination of transfusion requirement over a median follow-up of two years. 8, 31 Argon plasma coagulation (APC) has been found to be equally effective in the treatment of GAVE and superior in cost, convenience, and complication rates. 29 APC is a non-contact electrocoagulation technique using a jet of ionized argon gas to deliver monopolar current to the target tissues. 32 In a study of 26 patients treated with APC, transfusion requirement elimination was seen in 77% over a mean follow-up of 16 months. 33 The benefit of APC lies in the consideration that the depth of penetration can be easily controlled, thus avoiding excessive blood loss. We used this modality in both of our patients, with significant improvement in bleeding. Multiple sessions may be required to reduce future episodes and/or decrease transfusion dependence, as has been noted in our second patient.
Recently, Wells et al 34 reported a study demonstrating the superiority of endoscopic band ligation in the treatment of GAVE when compared to endoscopic thermal therapy. Endoscopic band ligation is the current standard of care for variceal ligation. In patients with GAVE, endoscopic band ligation resulted in increased hemoglobin levels and decreased blood transfusions and hospital admissions compared to endoscopic thermal therapy. Additionally, fewer treatment sessions were necessary, likely due to the ability of endoscopic band ligation to
Gastric antral vascular ectasia Page 10 Copyright ©2012 Marshfield Clinic treat a larger area of the mucosa at once. No randomized, prospective studies have been performed to conclusively demonstrate the superiority of endoscopic band ligation over conventional therapies, but it offers a promising new therapeutic option. 34 Before the advent of endoscopic therapy, GAVE was commonly treated by antrectomy. 3, 17, 18 However, surgical resection is often associated with significant morbidity and mortality and should be reserved for patients who do not respond to medical or endoscopic treatment. 
